HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The aim of the study was to evaluate longitudinal associations between HbA 1c levels, diabetes status and subsequent cognitive decline over a 10 year follow-up period. Data from wave 2 (2004–2005) to wave 7 (2014–2015) of the English Longitudinal Study of Ageing (ELSA) were analysed. Cognitive function was assessed at baseline (wave 2) and reassessed every 2 years at waves 3–7. Linear mixed models were used to evaluate longitudinal associations. The study comprised 5189 participants (55.1% women, mean age 65.6 ± 9.4 years) with baseline HbA 1c levels ranging from 15.9 to 126.3 mmol/mol (3.6–13.7%). The mean follow-up duration was 8.1 ± 2.8 years and the mean number of cognitive assessments was 4.9 ± 1.5. A 1 mmol/mol increment in HbA 1c was significantly associated with an increased rate of decline in global cognitive z scores (−0.0009 SD/year, 95% CI −0.0014, −0.0003), memory z scores (−0.0005 SD/year, 95% CI −0.0009, −0.0001) and executive function z scores (−0.0008 SD/year, 95% CI −0.0013, −0.0004) after adjustment for baseline age, sex, total cholesterol, HDL-cholesterol, triacylglycerol, high-sensitivity C-reactive protein, BMI, education, marital status, depressive symptoms, current smoking, alcohol consumption, hypertension, CHD, stroke, chronic lung disease and cancer. Compared with participants with normoglycaemia, the multivariable-adjusted rate of global cognitive decline associated with prediabetes and diabetes was increased by −0.012 SD/year (95% CI −0.022, −0.002) and −0.031 SD/year (95% CI −0.046, −0.015), respectively ( p for trend <0.001). Similarly, memory, executive function and orientation z scores showed an increased rate of cognitive decline with diabetes. Significant longitudinal associations between HbA 1c levels, diabetes status and long-term cognitive decline were observed in this study. Future studies are required to determine the effects of maintaining optimal glucose control on the rate of cognitive decline in people with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These tests have been shown to have high validity and reliability in the studies of others [16–18].”
From Digital exclusion and cognitive impairment in older people: findings from five longitudinal studies (2024) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 1×
“4%] [14]) and/or diabetes are associated with accelerated cognitive decline in an elderly population with normal cognition at baseline; and (2) to examine whether people with diabetes with better glycaemic control, as measured by HbA1c levels, show a similar or decreased rate of subsequent cognitive decline.”
BackgroundThe projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Cohort profile: The English longitudinal study of ageing
Steptoe, A., Breeze, E., Banks, J., & Nazroo, J. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys168 · Cited by 1,779
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Research works printed but not linked: 1
- Graig R Deverill C Pickering K Spronston K Mindell J Quality control of blood saliva and urine analytes Health Survey for England 2004: methodology and documentation 2006 London The Information Centre
Cited by
Items 201–279 of 279
Rajalakshmi, R., M., R. C., Naaz, R., Madhunapantula, S. V., Uthaiah, C. A., & Salimath, P. V. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1696711 · Cited by 1
“Similar findings have been reported in large cohort studies demonstrating stronger cognitive associations with HbA1c than with fasting glucose measures (Zheng et al., 2018; Xiao et al., 2025).”
Liu, Y., Luo, Z., Xu, Z., Feng, J. L., & Hou, L. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200671 · Cited by 3
“HbA1c concentrations were measured from venous blood samples: CHARLS used boronate affinity liquid chromatography, whereas ELSA measurements were performed using the Tosoh G7 analyzer [31].”
Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
Rachman, A., Sauriasari, R., Syafhan, N. F., Prawiroharjo, P., & Risni, H. W. (2022) · Kesmas National Public Health Journal · doi:10.21109/kesmas.v17i4.6303 · Cited by 3
Almani, S. A., Nazia, S., Shah, M. I., Abbasi, M., Kumar, S., & Feroze, Z. (2021) · Journal of Liaquat University of Medical & Health Sciences · doi:10.22442/jlumhs.2021.00790 · Cited by 1
Esmaeilzadeh, S., Hakala, P., Berg, P., Salmon, J., Rinne, T. E., & Pesola, A. J. (2024) · Journal of Activity Sedentary and Sleep Behaviors · doi:10.1186/s44167-024-00053-9 · Cited by 2
“Fibion® is validated for estimating moderate-to-vigorous physical activity and energy expenditure against indirect calorimetry [30].”
BackgroundChen, Y., Ren, C.-Y., & Yu, C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1435394 · Cited by 1
Li, S., Chen, H., Zhao, R., Wang, T., & Ye, J. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03555-z · Cited by 3
“Higher scores on all tests indicate better cognitive abilities [31].”
Cognitive Trajectory Before and After Cataract Surgery: A Population‐Based Approach
Joo, H., Diaz‐Ramirez, L. G., Chen, C. L., Sun, C. Q., Smith, A. K., Boscardin, W. J., & Whitlock, E. L. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19372 · Cited by 1
“…with age and other factors [12], some of which overlap with risk factors for cataract development like educational attainment [13–16] and diabetes [17–19], comparing rates of cognitive decline before versus after cataract surgery—among those who have cataract surgery, and among appropriate…”
Massa, F., Scavino, M., & Terrera, G. M. (2025) · Stats · doi:10.3390/stats8030074 · Cited by 1
“In particular, the intercept value corresponds to the average total recall score observed among cognitively healthy older adults in the English Longitudinal Study of Ageing (ELSA) [32].”
Association between cognitive impairment patient with solid cancer and insulin resistance
Gonda, K., Yaginuma, K., Rokkaku, Y., Horita, S., Maejima, Y., & Shimomura, K. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4739-5 · Cited by 5
Gómez-Martínez, C., Babió, N., Júlvez, J., Becerra‐Tomás, N., Martínez‐González, M. Á., Corella, D., Castañer, O., Romaguera, D., Vioqué, J., Alonso‐Gómez, Á. M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-768645/v1 · Cited by 1
Dongaonkar, B., Singh, A. D., Hurakadli, S. B., & Godbole, A. (2023) · medRxiv · doi:10.1101/2023.02.24.23286286 · Cited by 1
“Associations of high glycated hemoglobin and cognitive change have also been observed in diverse populations (Jana et al., 2017; `Maan et al. 2021; Mimenza-Alvarado et al., 2020; Zheng et al., 2018).”
BackgroundSchlechter HbA1c-Wert ebnet Weg zur Demenz
Stirban, O. A. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1302-8
Schlechte HbA1c-Werte, kognitiver Verfall
Stirban, O. A. (2018) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-018-0931-0
Riding, S. (2018) · Primary Health Care · doi:10.7748/phc.2018.e1416
Mechanisms of diabetes and dementia
Puttanna, A. (2019) · Practical Diabetes · doi:10.1002/pdi.2234
Management of Older People With Diabetes - A Focus On Mental Functions
Abdelhafiz, A. H. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2002113
Midlife diabetes and the risk of dementia
Dyer, A. H., & Kennelly, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00006-9
Короленко, Т. А., Dubrovina, N. I., Ovsyukova, M. V., Bgatova, N. P., Pupyshev, A. B., Ануфриенко, Е. В., Lin, C., & Zavjalov, E. L. (2020) · IEEE Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB) · doi:10.1109/csgb51356.2020.9214662
“Role of diabetes in cognitive decline development [9]; and impaired cognitive flexibility [10] was discussed.”
BackgroundPatoine, P.-L. (2021) · Biosemiotics/Biosemiotics. Bookseries · doi:10.1007/978-3-030-67115-0_4
Shen, J., Li, K., Yu, H., Ding, B., Xiao, R., & Ma, W. (2021) · Research Square · doi:10.21203/rs.3.rs-577863/v2
Shen, J., Li, K., Yu, H., Ding, B., Xiao, R., & Ma, W. (2021) · Research Square · doi:10.21203/rs.3.rs-577863/v3
Brève: HbA 1c , diabète et déclin cognitif
Y.-M., D. (2018) · Option/Bio · doi:10.1016/s0992-5945(18)30043-6
Assessment of Cognitive Function in Diabetic Patients – A Case-Control Study
Al-Tamimi, A. I., Aljirdabi, N. S., & Almosawi, S. (2022) · Journal of the Bahrain Medical Society · doi:10.26715/jbms.34_2022_2_2
Adaptation of Gut Microbiota to Modern Dietary Sugars and Sweeteners
李, 梦. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1291193
Progress on Factors Influencing Cognitive Dysfunction in Patients with Type 2 Diabetes
刘, 敏. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.132351
A Review on Executive Dysfunction in Type 2 Diabetes Mellitus Assessment and Management
Jani, P., & Verma, N. (2023) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20230128
Association of Time in Range with Cognitive Impairment in Type 2 Diabetic PatientsPreprint
Liu, Y., Liu, Y., Qiu, H.-N., Haghbin, N., Li, J., Li, Y., Jiang, W., Xia, L., Wu, F., Lin, C.-Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3227918/v1
Chen, X., Li, J., Liu, J., Liu, X., Deng, M., Dong, X., & Yang, Y. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/175973
“Both of the two memory tests have good construct validity and consistency 21 .”
BackgroundNurhayati, P., Irham, A. M., Pramana, I. D. B. K. W., & Harahap, H. S. (2022) · Unram Medical Journal · doi:10.29303/jk.v11i1.4342 · Cited by 5
Hua, J., Dong, J., Chen, Y., Li, H., & Chen, Q. (2024) · medRxiv · doi:10.1101/2024.11.16.24317444
Zachara, R., Właszczuk, A., de Carrillo, D. G., Gorzkowska, A., & Jędrzejowska–Szypułka, H. (2024) · Research Square · doi:10.21203/rs.3.rs-5234665/v1
Kelly, N. R., Kosty, D. B., Bodovski, Y., Blackwell, C. K., Ganiban, J. M., Neiderhiser, J. M., Dabelea, D., Gilbert‐Diamond, D., Aschner, J. L., Bastain, T. M., et al. (2025) · Journal of Behavioral Medicine · doi:10.1007/s10865-024-00543-w
Diabetes With Elevated A1C is Related to Perceptual Speed Decline in Older Adults
Biswas, R., Capuano, A. W., Moran, C., Bennett, D., & Arvanitakis, Z. (2025) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000663
“9,10 Further research is needed to clarify the complex relationship of longitudinal A1C data and related factors (metabolic and otherwise) with decline in cognition and dementia.”
彭, 妩. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152442
Effect of short term strength training on executive function in type 2 diabetes mellitus
Jani, P. A., & Verma, N. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20250682
Foudjo, B. U. S., Aphrodite, C. T., Ngnie‐Teta, I., Kenmoe, J., Latsap, D., Navti, L. K., & Nantia, E. A. (2025) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20251001.11
Zong, Y., Han, Z., Xu, L., Zhang, Y., Chen, W., & Liu, T. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11134-y · Cited by 1
Mkhabela, S. M., Jaya, Z. N., & Thembane, N. (2025) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v6i6.1683
Han, S., Naderi, E., Wang, K., Ma, Y., Biessels, G. J., & Ahmadizar, F. (2025) · medRxiv · doi:10.1101/2025.06.11.25329399
Pan, Y., Ji, M., Liang, J., Ma, J., Zhang, W., Liu, Y., Dai, Y., Gao, D., Zhang, Y., Xie, W., et al. (2025) · medRxiv · doi:10.1101/2025.06.27.25330394
Self-citationAntidiabetic Drugs and Risk of Dementia: A Mendelian Randomization StudyPreprint
Wei, J., Chen, H., Li, S., Xie, W., Xiang, S., Huang, W., Wang, Z., & Jin, Z. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5386740
Self-citationPrevalence of Cognitive Decline in Individuals With Diabetes in the United States
Patel, S., Joshi, M., Rawat, S., Agarwal, P., & Fastring, D. R. (2025) · Cureus · doi:10.7759/cureus.90408
“Over a 10-year period, study participants with diabetes or elevated HbA1c experienced greater declines in global cognition, memory, and executive function compared to those with normal glucose levels [12].”
Zachara, R., de Carrillo, D. G., Właszczuk, A., Gorzkowska, A., Mazur, W., & Jędrzejowska–Szypułka, H. (2025) · Neurology International · doi:10.3390/neurolint17110180
“Solomon also suggested the influence of hypolipidemic treatment on improving episodic memory and better results in psychomotor memory tests [30].”
Tanioka, R., Onishi, K., Betriana, F., Bollos, L. A. C., Kwan, R. Y. C., Tang, A. C. Y., Zhao, Y., Mifune, Y., Mifune, K., & Tanioka, T. (2025) · Psychiatry International · doi:10.3390/psychiatryint6040136 · Cited by 2
“Comorbid conditions, such as chronic hyperlipidemia, hypertension, and diabetes, impair attention, processing speed, memory, and executive function, partly due to reduced blood flow to the prefrontal cortex [12,29,30].”
Sumitomo, K., Higashibeppu, Y., Tajima, M., Sato, H., & Sugiyama, E. (2025) · Psychogeriatrics · doi:10.1111/psyg.70117 · Cited by 2
Link between hyperglycemia and onset of neurodegeneration: Early clinical evidence
Mishra, A., & Hota, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00008-6
Malakapogu, P., Shyma, Z., Shetty, S., Bagchi, D., & Miraj, S. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00032-3
Risk of dementia in diabetes mellitus: a mechanistic endeavor
Samanta, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00029-3
Wang, Y., Wu, Z., Duan, L., Liu, S., Chen, R., Sun, T., Wang, J., Zhou, J., Wang, H., & Huang, P. (2024) · Figshare · doi:10.6084/m9.figshare.25770330
Wood, D., Evangelopoulos, D., Beevers, S. D., Kitwiroon, N., Demakakos, P., & Katsouyanni, K. (2024) · Figshare · doi:10.6084/m9.figshare.25546959
Ma, Y., Hua, R., Yang, Z., Zhong, B., Yan, L., & Xie, W. (2021) · Figshare · doi:10.6084/m9.figshare.16916431
Self-citationYuan, Z., Liu, H., Zhou, R., Gu, S., Wu, K., Huang, Z., Zhong, Q., Huang, Y., Chen, H., & Wu, X. (2024) · Figshare · doi:10.6084/m9.figshare.26587116
Jian, Y., Cheng, L., Hong, Y., Li, Z., Li, C., Ban, X., Zhu, L., & Gu, Z. (2025) · Food Nutrition · doi:10.1016/j.fnutr.2025.100048
He, T., Huang, G.-M., Li, H.-L., Zhong, R., Liu, H.-M., Zhong, W.-B., & Liu, X.-C. (2025) · BMC Public Health · doi:10.1186/s12889-025-26038-0
Kamaeva, K. S., & Bykov, Y. V. (2026) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2025-40-4-37-44
Yang, P., Ji, M., Liang, J., Ma, J., Zhang, W., Liu, Y., Dai, Y., Gao, D., Zhang, Y., Xie, W., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2024-095515
Self-citationUm, K., Kim, B. J., & Ying, G.-S. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110831
Dai, Y., Liu, Y., Pan, Y., Zhu, M., Diao, X., Yang, X., Ma, J., Gao, D., Zhang, Y., Ji, M., et al. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100548
“Further details are available in previous studies [7,32].”
Self-citationFrison, É. (2019) · theses.fr (ABES) · doi:10.70675/a527bd03zb814z44e5z8848z942b662a0847 · Cited by 2
Firdoos, S., Dai, R., Shah, F. A., & Younas, Z. (2026) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70120
Cognitive reserve, physical disorders and the trajectory of psychological and cognitive function
Chen, H.-W., Li, Q.-R., Zhong, Q., Wang, S.-A., Xu, Z.-Y., Cao, B., Liu, K., & Wu, X.-B. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.108938
Li, T., Zhang, Z., Ma, R., Chu, H., Qian, Y., Xia, J., Li, P., Wang, Z., & Zou, T. (2026) · Quality of Life Research · doi:10.1007/s11136-026-04238-4
“Specifically, each participant’s raw score was standardized by subtracting the sample mean and dividing by the sample standard deviation (SD) [28].”
Zhou, Y., Qian, S., Pan, C., & Tang, Y. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121894
Post-stroke cognitive decline among women in midlife
Jacobs, M., Evans, E., & Ellis, C. (2026) · Women s Health · doi:10.1177/17455057261444148
“39 Therefore, a Z -score equal to 1 would describe a cognitive function 1 SD above the mean score at visit 4.”
Lin, S., Lu, X., Liang, Q., Huang, H., Chen, S., Chen, Q., Wei, H., & Qiu, Y. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04157-5 · Cited by 1
Shen, Y., Shi, X., Wang, G. Y., Sun, H., Zhang, K., 母杰丹, Zhou, Y., Wang, H., Guan, Z., & Li, X. (2026) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2026.100078
Yang, Y.-L., Li, J.-B., Yang, C.-J., Wen, L., Wang, S.-J., Wang, N.-N., & Jia, X.-C. (2026) · Cognitive Processing · doi:10.1007/s10339-026-01377-x
“This study generated z score of cognitive function test data for subsequent data analysis (Zheng et al. 2018; Xie et al. 2019).”
Dhanasekara, C. S., Kahathuduwa, C. N., & Neugebauer, V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1836968
Tunç, A. E. B., Tunç, S., Atagün, M. İ., & Köse, S. (2026) · Brain Sciences · doi:10.3390/brainsci16070770
“Longitudinal studies further indicate that higher HbA1c levels and greater glycemic variability are associated with accelerated cognitive decline, particularly in memory and executive functions [61–63].”
Xu, L., Tong, Q., & Ye, H. (2026) · Research Square · doi:10.21203/rs.3.rs-10279428/v1
Ren, J., Lv, T., Mao, Q., & Zhang, Y. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/6628845
“Indeed, clinical and epidemiological studies have suggested that variations in HbA1c levels, even within the normal range (5.7%–6.5%), may still pose potential health risks [14, 15].”
InfluentialHariharan, R., Bell, S., Majid, A., Feehan, J., de Courten, B. V., & Mousa, A. (2026) · Medical Sciences · doi:10.3390/medsci14050520
Cognitive Ageing in Healthy Adults in India: A Cross-Sectional Multimodal Study ProtocolPreprint
Vasudevan, H., Chelluri, S., Umapathy, G., Vinod, P. K. U., Sepuri, N. B. V., Krishnamoorthy, T., Bapi, R. S., & Dongaonkar, B. (2026) · medRxiv · doi:10.64898/2026.09.04.26362232
Cognitive impairments in prediabetes and diabetes: From pathogenesis to comprehensive therapy
Пизова, Н. В., Pizov, A. V., & Solovyov, I. N. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-305
Gostyńska, A., Posadzy-Małaczyńska, A., Kruszyńska, N., Romanowska, M., Puszcz, A., Piesiak, K., Konopelski, T., & Ostrowska, B. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197391
“Chronic hyperglycemia, even at prediabetic levels, correlates with a faster rate of global cognitive decline and microstructural brain damage [7,8].”
Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
Corbali, O., Menon, P., Corbali, H. I., Jagannathan, R., & Levey, A. I. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70487
“The risk of dementia with diabetes increases with greater diabetes severity, longer disease duration, history of hypoglycemia, or the presence of comorbid conditions [8–11].”
Wei, L., Liu, T., Yang, S., Chu, Y., & Han, Y. (2026) · Journal of Dentistry · doi:10.1016/j.jdent.2026.107129
Metadata
- Authors
- Zheng, F., Yan, L., Yang, Z., Zhong, B., & Xie, W.
- Affiliations
- Chinese Academy of Sciences (CN)
- Imperial College London (GB)
- Peking University (CN)
- Corresponding author
- Xie, Wuxiang
- Venue
- Diabetologia
- Published
- 2018-01-25
- Volume
- 61
- Issue
- 4
- Pages
- 839-848
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC6448974
- OpenAlex
- W2791177277
- Cited by
- 280
- References
- 32
- Citations by year
- 2026: 31 · 2025: 54 · 2024: 35 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 24 · 2019: 24 · 2018: 13
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Academy of Medical Sciences (P56804)
- National Natural Science Foundation of China (81601176)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- HbA1c, diabetes mellitus, prediabetes, cognitive decline, memory, executive function, older adults, English Longitudinal Study of Ageing, glycemic control, dementia risk, HbA1c thresholds, cognitive function trajectories, HbA1c trajectories, diabetes subtypes
- MeSH terms
- Aged, Blood Glucose, Cognition, Cross-Sectional Studies, Diabetes Mellitus, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Memory, Middle Aged, Reproducibility of Results, Treatment Outcome, Diabetes Complications, Executive Function, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.